HR-3029 : Still Just a Bill

Improving Low-Income Access to Prescription Drugs Act of 2019

This bill provides statutory authority for the Centers for Medicare & Medicaid Services transition program under the Medicare prescription drug benefit for limited-income, newly eligible individuals (i.e., individuals who are eligible for subsidies and have not yet enrolled in, or whose coverage has not yet taken effect under, a Medicare or Medicare Advantage prescription drug plan). The program's coverage provides immediate access to covered drugs at the point of sale as soon as the individual becomes eligible for subsidies; coverage also applies retroactively for dual eligible individuals and for individuals who receive benefits under the Supplemental Security Income program.

Action Timeline

Action DateTypeTextSource
2019-06-04CommitteeSubcommittee Hearings Held.House committee actions
2019-05-29CommitteeReferred to the Subcommittee on Health.House committee actions
2019-05-28IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2019-05-28IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2019-05-28IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Health
See Subjects
  • Health care coverage and access
  • Medicare
  • Poverty and welfare assistance
  • Prescription drugs

Related Bills

See Related Bills